Neuroblastoma is a tumour arising from anomalies in the development of the sympathic nervous system and still accounts for 13% of all cancer-related death in children due to resistant, relapsing and metastatic diseases. There is an urgent need for the development of new treatment against high-risk relapsed neuroblastoma. Overview: Here we will discuss the ICR […]

Webinar
Apr 24 2024
11:00 am - 12:00 pm
Location Name